Mr. Jarosz is a Founding Partner of Cartesian Capital Group, a global private equity firm managing assets of more than $2.5 billion. Prior to creating Cartesian, Mr. Jarosz helped establish the third-party global private equity practice of American International Group and practiced corporate law in the private equity practice of Debevoise & Plimpton. Active in the healthcare and biotechnology sectors for more than twenty years, Mr. Jarosz has assisted investee companies across the full range of their activities from drug discovery, to mergers and acquisitions, and capital markets strategies in both the private and public markets. Mr. Jarosz has held numerous directorships and served as the Chief Executive Officer of iCo Therapeutics from 2020 until its amalgamation with Satellos in 2022. Mr. Jarosz is a graduate of the University of Montana and received an M.A. in Law and Diplomacy from the Fletcher School at Tufts University, and a J.D. from Harvard Law School.